Seo Da Hea, Cho Yongin, Seo Seongha, Ahn Seong Hee, Hong Seongbin, Ha Kyung Hwa, Shim Jee-Seon, Kim Hyeon Chang, Kim Dae Jung, Kim So Hun
Department of Endocrinology and Metabolism, Inha University College of Medicine, Incheon 22212, Korea.
Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea.
J Clin Med. 2022 Apr 26;11(9):2440. doi: 10.3390/jcm11092440.
We aimed to investigate the association between a new definition of metabolic health (MH) and subclinical atherosclerosis in a cohort of patients without previous cardiovascular disease (CVD). In total, 7824 community-dwelling adults were categorized as normal weight, overweight, or obese. Metabolically healthy obesity (MHO) was defined as obesity accompanied by all of the following criteria: systolic blood pressure (BP) < 130 mmHg, no use of BP-lowering medication, waist-hip ratio <0.832 (women) and <0.887 (men), and no prevalent diabetes. Carotid atherosclerosis was defined as carotid plaque or mean carotid intima-media thickness ≥ 1.1 mm. The prevalence of carotid atherosclerosis was 8.3% and 1113 (14.2%) patients were classified as having MHO. All individuals classified as metabolically unhealthy were at an increased risk of carotid atherosclerosis independent of body mass index categories. Conversely, the risk of carotid atherosclerosis in individuals with MHO was not significantly increased compared to that in metabolically healthy normal weight participants (hazard ratio 1.20, 95% confidence interval 0.87−1.67). This new definition of MH was able to identify people with MHO without an increased risk of CVD in an Asian community cohort.
我们旨在调查一组既往无心血管疾病(CVD)患者中,代谢健康(MH)的新定义与亚临床动脉粥样硬化之间的关联。总共7824名社区居住成年人被分类为正常体重、超重或肥胖。代谢健康型肥胖(MHO)被定义为肥胖且伴有以下所有标准:收缩压(BP)<130 mmHg,未使用降压药物,腰臀比<0.832(女性)和<0.887(男性),且无糖尿病。颈动脉粥样硬化被定义为颈动脉斑块或平均颈动脉内膜中层厚度≥1.1 mm。颈动脉粥样硬化的患病率为8.3%,1113名(14.2%)患者被分类为患有MHO。所有被分类为代谢不健康的个体,无论体重指数类别如何,颈动脉粥样硬化风险均增加。相反,与代谢健康的正常体重参与者相比,MHO个体的颈动脉粥样硬化风险没有显著增加(风险比1.20,95%置信区间0.87 - 1.67)。这种MH的新定义能够在一个亚洲社区队列中识别出患有MHO但无CVD风险增加的人群。